Menopausal Symptoms

New Research from the CWMH: Escitalopram (Lexapro) for Hot Flashes

For decades, estrogen has been used to treat menopausal symptoms, including night sweats and hot flashes.  However, after studies reported that estrogen increases the risk of cardiovascular disease and breast cancer, many patients and clinicians have looked into alternative treatments for hot flashes, including selective serotonin reuptake inhibitors (SSRIs). According to a new study published in the Journal of the American Medical Association, treatment with the selective serotonin reuptake inhibitor (SSRI) escitalopram (Lexapro) significantly reduces the frequency and severity of menopausal hot flashes compared with placebo.

By |2016-03-28T13:02:56-04:00February 3rd, 2011|Menopausal Symptoms, Research at CWMH, Treatment|Comments Off on New Research from the CWMH: Escitalopram (Lexapro) for Hot Flashes

Insomnia Across the Female Life Cycle

In the July 2010 issue of Current Psychiatry, you will find a thorough review on the evaluation and treatment of insomnia in women across the life cycle.  The bottom line is that many women experience insomnia during times of hormonal transition.  The authors provide some useful guidelines for evaluating women who present with sleep problems (taken from Table 2):

By |2025-12-11T09:41:06-04:00October 12th, 2010|Menopausal Symptoms, Postpartum Psychiatric Disorders, Prevalence & Risk Factors, Psychiatric Disorders During Pregnancy, Sleep Disorders|Comments Off on Insomnia Across the Female Life Cycle

The Truth About Bioidentical Hormones

In increasing numbers, women who are candidates for hormonal replacement therapy are requesting “bioidentical” rather than synthetic hormones.  Although there is a tendency to think of bioidentical hormones as “all-natural”, they, like synthetic hormones, are manufactured in the laboratory.  In contrast to synthetic hormones, they are chemically identical to the hormones produced by the human body; synthetic hormones are structurally different yet are designed to have similar biological effects as naturally produced hormones.

By |2015-04-14T22:59:40-04:00November 23rd, 2009|Hormone Therapy, Menopausal Symptoms, Treatment, Vasomotor Symptoms|Comments Off on The Truth About Bioidentical Hormones

Pregabalin (Lyrica) for the Treatment of Hot Flashes

Although estrogen is highly effective for the treatment of hot flushes, many women are reluctant to use hormone therapy to manage these symptoms, given recent concerns that estrogen may carry certain risks.  Several studies have demonstrated that gabapentin (Neurontin) and certain antidepressants, including paroxetine (Paxil) and venlafaxine (Effexor), may be useful non-hormonal treatments for the management of hot flashes.  Data presented at the annual meeting of the American Society of Clinical Oncology indicate that pregabalin (Lyrica), an anticonvulsant drug similar to gabapentin, may also be helpful for alleviating hot flashes.

By |2015-08-12T15:19:18-04:00September 21st, 2009|Medication, Menopausal Symptoms, Treatment, Vasomotor Symptoms|Comments Off on Pregabalin (Lyrica) for the Treatment of Hot Flashes

Hot Flashes or Depression: Which Comes First?

Hot flashes and depression are both common symptoms of the menopause transition.  Several studies have found a relationship between depression and hot flashes: depressed women are more likely to experience hot flashes and women with hot flashes are more likely to have depression.  Other studies have found no association between hot flashes and depression. 

By |2015-08-12T15:09:09-04:00September 14th, 2009|Depressive Disorders, Menopausal Symptoms, Prevalence & Risk Factors, Vasomotor Symptoms|Comments Off on Hot Flashes or Depression: Which Comes First?

Depression and Menopausal Symptoms Go Together

It is well established that women are at increased risk for developing depression compared to men.  It has been hypothesized that this vulnerability to depression may be hormonally mediated, and several longitudinal studies have documented an increased risk of depressive symptoms during perimenopause or the menopausal transition.  Based on the results of two prospective cohort studies, approximately one-third of women will develop their first episode of depression during the menopausal transition.  (Cohen LS et al 2006, Freeman EW et al 2006).

By |2015-08-12T14:58:10-04:00August 17th, 2009|Depressive Disorders, Menopausal Symptoms, Prevalence & Risk Factors|Comments Off on Depression and Menopausal Symptoms Go Together

Use of Complementary and Alternative Medicines for Menopausal Hot Flashes

Approximately seventy percent of all women experience hot flashes and/or night sweats (also called vasomotor symptoms) during the menopause transition (Stearns et al. 2002).  Until recently, estrogen therapy was the treatment of choice for most women who sought treatment for hot flashes.  Since the results of the Women's Health Initiative in 2002 noted risks of prolonged use of hormone therapy in older postmenopausal women (Roussouw et al. 2002), many women pursue other treatments for their hot flashes, including over-the-counter complementary and alternative medicines (CAMs), including soy isoflavones, black cohosh, and omega-3 fatty acids.  However, there is limited evidence to support the use of these treatments for hot flashes to date.

By |2015-08-12T14:41:43-04:00May 29th, 2009|Alternative & Complementary, Menopausal Symptoms, Treatment, Vasomotor Symptoms|Comments Off on Use of Complementary and Alternative Medicines for Menopausal Hot Flashes

Mood and well-being after removal of both ovaries

The risk of depression after removal of both ovaries (also called bilateral oöphorectomy or surgical menopause) is a major factor for women to consider when they confront medical problems that require removal of the uterus (called a hysterectomy).  Many women are advised to consider having their ovaries removed when they are having the uterus removed.  Sometimes removal of the ovaries is required to fully treat the condition leading to surgery, but other times it is suggested as a precaution to reduce the risk of ovarian cancer.  Removal of both ovaries in a premenopausal woman results in an abrupt withdrawal of estrogen, progesterone, and testosterone.  Therefore removing both ovaries (rather than just one or neither ovary) may have significant effects on mood and well-being in women.

By |2015-08-12T14:02:54-04:00February 24th, 2009|Depressive Disorders, Menopausal Symptoms, Prevalence & Risk Factors|Comments Off on Mood and well-being after removal of both ovaries

Phytoestrogens and Menopause

For decades, estrogen was used as a component of hormone replacement therapy to treat menopausal symptoms and for anticipated preventative health benefits in women with prostesterone, or as a monotherapy hormone treatment in women after hysterectomy, but after studies reported that long-term estrogen increase the prevalence of cardiovascular events and breast cancer, many patients and researchers have looked into alternative treatments such as food or products containing phytoestrogens.  Phytoestrogens are weak plant-derived estrogens that are structurally similar to estrogen hormones produced by the body.

By |2015-08-12T12:26:11-04:00January 20th, 2009|Alternative & Complementary, Depressive Disorders, Menopausal Symptoms, Treatment|Comments Off on Phytoestrogens and Menopause

Testosterone Patch Improves Sexual Functioning in Postmenopausal Women

Sexual dysfunction is common among postmenopausal women and include a spectrum of problems, including low (or hypoactive) sexual desire, decreased satisfaction, and discomfort.   Reports indicate that the prevalence of hypoactive sexual desire ranges from 9% in naturally postmenopausal women up to 26% in younger surgically postmenopausal women.   A recent study published in the New England Journal of Medicine evaluates the effectiveness of the testosterone patch for postmenopausal women with low sexual desire.

By |2015-08-12T12:08:50-04:00December 1st, 2008|Hormone Therapy, Menopausal Symptoms, Sexual Health, Treatment|Comments Off on Testosterone Patch Improves Sexual Functioning in Postmenopausal Women
Go to Top